Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

630
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
630

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease Summit.

JACC. Advances·2026
Same author

Future-informed FOCAL MODE: a multimodal deep learning framework for forecasting dissolved oxygen in reservoirs.

Environmental monitoring and assessment·2026
Same author

Generation and characterization of iPSC models from HIV-1-positive individuals with divergent clinical outcomes.

Stem cell reports·2026
Same author

Machine learning models incorporating genotype and ancestry improve severe asthma risk prediction.

Scientific reports·2025
Same author

The Association of Hand Dominance With the Development of Breast Cancer-related Lymphedema After Mastectomy: A Retrospective Analysis.

Plastic and reconstructive surgery. Global open·2025
Same author

Modelling the transport and deposition of sediment-microplastics fluxes in a braided river, using Delft3D.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2025

Related Experiment Video

Updated: Dec 6, 2025

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
11:12

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

17.7K

Predicting Alzheimer's Disease Using Driving Simulator Data.

Ryan Blanchette, Anahita Khojandi, Daniel Cox

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |October 6, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Early detection of Alzheimer's Disease (AD) is possible using driving simulator data. Machine learning accurately identified AD patients by analyzing driving behaviors like pothole avoidance and reaction time.

    More Related Videos

    Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
    07:15

    Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

    Published on: December 18, 2020

    4.8K
    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
    09:38

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Published on: November 14, 2017

    15.4K

    Related Experiment Videos

    Last Updated: Dec 6, 2025

    Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
    11:12

    Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

    Published on: September 18, 2012

    17.7K
    Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
    07:15

    Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

    Published on: December 18, 2020

    4.8K
    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
    09:38

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Published on: November 14, 2017

    15.4K

    Area of Science:

    • Neurology
    • Artificial Intelligence
    • Gerontology

    Background:

    • Early detection of Alzheimer's Disease (AD) is crucial for patient outcomes.
    • Complex task performance, like driving, may indicate early cognitive decline.
    • Driving ability can reflect functional status in neurodegenerative diseases.

    Purpose of the Study:

    • To investigate the use of driving simulator data for classifying Alzheimer's Disease patients and controls.
    • To evaluate the efficacy of machine learning algorithms in AD detection using driving metrics.

    Main Methods:

    • Utilized a driving simulator to collect performance data from AD patients and healthy controls.
    • Applied machine learning algorithms, specifically random forest classifier, for data analysis and classification.
    • Identified key driving features indicative of Alzheimer's Disease.

    Main Results:

    • The random forest classifier achieved high accuracy in discriminating AD patients from controls (AUC = 0.96).
    • Achieved high sensitivity (87%) and specificity (93%) in AD classification.
    • Key predictive features included Pothole Avoidance, Road Signs Recalled, Inattention Measurements, Reaction Time, and Detection Times.

    Conclusions:

    • Driving simulator data, analyzed by machine learning, offers a sensitive method for early Alzheimer's Disease detection.
    • Driving performance metrics correlate with known cognitive deficits associated with AD.
    • This approach shows promise as a non-invasive tool for assessing functional status in early AD.